CHINA LEX PHARMA LAW NEWSLETTER
Vol. 2 , No.28 - October 25, 2001
TOPICS THIS ISSUE:
- Chinese Customs Uncover Largest Case of Fake Viagra in Asia
- China to Strengthen Fight Against Tuberculosis
- Locally Produced Anti-AIDS Drug Promising
- China Bone Marrow Bank Expanding Donor Pool
- Chindex Approved to Build Second Hospital
- List of China GMP Facilities (Continued)
Chinese Customs Uncover Largest Case of Fake Viagra in Asia
The largest batch of counterfeit Viagra pills in Asia has been seized in eastern China.
Approximately 240,000 fake versions of the sex-enhancing Viagra pill were found by Customs officials in China. A man residing in the eastern city of Nanjing was arrested in connection with the seizure of the drugs and confessed to planning to sell them.
The case, jointly conducted by Customs officials in Tianjin and Shanghai, involved 90,000 pills found in Tianjin and 150,000 more pills in Shanghai.
Li had supposedly declared the pills as "pearl calcium". Pfizer, the legitimate manufacturer of Viagra, says the recent capture is the largest case of counterfeit Viagra pills in Asia so far.
(Source: Agence France Presse)
China to Strengthen Fight Against Tuberculosis
A senior health official in China recently said that the country will set up an efficient and ongoing medical infrastructure to fight against tuberculosis, with an ultimate goal of curing four million tuberculosis patients by 2010.
Yin Dakui, Vice Minister of Health, made the statement at a national meeting of anti-phtisis being held in the capital of the southwestern China Guizhou Province.
According to Yin, China is one of 22 countries in the world which suffer from severe tuberculosis. Latest statistics show that there are presently five million tuberculosis patients in China, accounting for 56% of the total number of tuberculosis patients in the Western Pacific Region.
The Ministry of Health and some related ministries have prepared a ten-year plan to control the disease. So far, China has utilized loans from the World Bank to carry out tuberculosis treatment projects for 560 million people in 13 provinces across the country.
In addition, the country will invest RMB 40 million (US $4.8 million) annually to establish a special foundation to prevent and control the spread of the disease.
(Source: Xinhua News Agency)
Locally Produced Anti-AIDS Drug Promising
A drug recently produced by the Northeast Pharmaceutical Factory in China's northeast Liaoning Province has brought hope to China's acquired immune deficiency syndrome (AIDS) sufferers.
Zidovudine or AZT, the first AIDS drug to gain approval for large-scale, worldwide production, has proven effective in reducing mother-to-child transmission of the virus. In the past, due to a lack of locally produced AIDS drugs, many patients in China have had to use imported AZT drugs which have an annual cost of RMB 70,000 (US $8,434) per person.
At the end of 2000, China was reported to have 22,517 people infected with the human immunodeficiency virus. As most of those afflicted live in rural or poverty-stricken areas, drug costs have been far out of reach for most AIDS sufferers.
Analysts believe that the lower-priced AZT produced by the Northeast Pharmaceutical Factory, which some sources say has already been exported, has a higher curative effect and will greatly ease patients' symptoms.
It has been learned that related sectors will use their technical advantages to develop more derivatives of the drug and build the nation's first anti-AIDS drug base.
There are currently 17 varieties of anti-AIDS drugs in the world, seven of which have been imported by China.
(Source: Xinhua News Agency)
China Bone Marrow Bank Expanding Donor Pool
The China Bone Marrow Bank is planning to expand its database of bone marrow to 100,000 people within five years.
The plan calls for the national bone marrow bank to improve storage facilities and establish bone marrow transplant centers in a third of the nation's provinces and municipalities.
Roughly 4 people per 1000 suffer from Leukemia in China. There are currently four million people in China waiting for bone marrow transplants as the number of cases of Leukemia increases by 40,000 per year.
Because of a shortage of blood donors and a low rate of successful blood matches suitable for transfusions, many people are forced to seek marrow matches from abroad.
Bone-marrow transplants help leukemia patients rebuild their weakened blood systems. Presently there are only about 30,000 registered blood donors in China, much lower than the 3.7 million registered donors in Europe.
It is hoped that the bone-marrow bank will collect 100,000 marrow donors in order to create a standard data retrieval system of bone marrow donors.
The China Bone Marrow Bank is the only marrow bank at the national level and was initiated by the Red Cross Society of China.
In order to gain support for donations, a large benefit concert will be held in the eastern Zhejaing province with proceeds going directly to the China Marrow Bank.
(Source: People's Daily)
Chindex Approved to Build Second Hospital
The Chinese Ministry of Health has approved Chindex's plans for the building of a new hospital in Shanghai.
Chindex International Inc., an American company providing Western medical and healthcare products and services in China, opened their first hospital, the Beijing United Family Hospital, in 1997.
"Following the tremendous success we have had with our first hospital, Beijing United, we are now ready for the next step in the development of the Chindex Healthcare Network" said Roberta Lipson, President and CEO of Chindex speaking in Beijing about the upcoming plans for the Shanghai United Family Hospital.
The hospital will be a joint venture between Chindex and Changning District Central Hospital, with the American company as a majority holder of shares. It will be modeled after the Beijing hospital.
"The system offers international healthcare services at a profitable return for the company, and also extends this quality of service into the huge local Chinese market. We believe the growth potential to be tremendous, " Lipson said, "Future Chindex hospitals are in the planning stages now as well."
If all goes according to plan, it is hoped that the 50-bed hospital will open in 2002.
(Source: Business Wire)
VISITING US IN BEIJING?
Turn Your PDA Into A Tour Guide
Beijing City guide for Palm OS 3.5
1000 Chinese Character TAXI Cards
1000 Super descriptions ONLY US $18.95
www.redBANG.com
NEVER EVER LOST
What the professionals have said:
I tried the redBANG application,
It is the most thorough guide I've seen!
Ava Mason
Handango Business Development
List of China GMP Facilities (Continued)
Name of Enterprise | Certified Scope |
251. Henan Yuansheng Pharmaceutical Co., Ltd. | High Dose Injection |
252. Changchun Lierfan Pharmaceutical Co., Ltd. | Freeze-dried Powder Injection |
253. Changchun Taiermao Medical Device Co., Ltd. | Anticoagulant |
254. Xuzhou Wanbang Biochemical Pharma Co., Ltd. | Freeze-dried Powder Injection, Tablet, Capsule |
255. Xuzhou Wanbang Biochmeical Pharma Co., Ltd. | Low Dose Injection |
256. Guangdong Changyi Pharma Co., Ltd. | Powder Injection (Cephalosporin) |
257. Shanghai Clone High-Tech Co., Ltd. | PCR workshop |
258. Beijing Sihuan Shidai Bio-Pharma Co., Ltd. | Freeze-dried Powder Injection, Low Dose Injection |
259. Zhoushan Kangenbei Pharma Co., Ltd | High Dose Injection |
260. Yichang Sanxia Pharmaceutical Co., Ltd. | High Dose Injection |
261. Shanghai Haiji Pharma Bio-Engineering Co., Ltd. | Recombinant Granulocyte-Macrophage Stimulus factor workshop |
262. Qingdao Jinfeng Pharma Co., Ltd. | High Dose Injection |
263. Ningpo Dachang Pharma Co., Ltd. | Capsule |
264. Beijing Shuanghe Pharma Co., Ltd. | High Dose Injection |
265. Zhejiang Yaojiang Pharma Co., Ltd. | Low Dose Injection |
266. Guangxi Guinan Pharma Co., Ltd. | Powder Injection (Cephalosporin) |
267. Hebei Yuikang Pharma Co., Ltd. | High Dose Injection |
268. Handan Yongjun Pharma Co., Ltd. | High Dose Injection |
269. Guangdong Xiangxue Pharma Co., Ltd. | Oral Liquid |
270. Zhuhai Lianbang Pharma Co., Ltd. | Raw Material (Penicillin),(Halosporin), Powder Injection (Penicillin) |
271. Jiangsu Kangqi Pharma Co., Ltd. | High Dose Injection |
272. Jiangxi Pharma Co., Ltd. | High Dose Injection |
273. Guangdong Yongkang Pharma Co., Ltd. | High Dose Injection |
274. Jiangxi Shangrao Kangda Pharma Co., Ltd. | High Dose Injection |
275. Shenyang Beilang Pharma Co., Ltd. | High Dose Injection |
276. Shenyang 1st Pharmaceutical Factory | High Dose Injection |
277. Jiangxi Gannan Pharmaceutical Factory | High Dose Injection |
278. Anhui Xinli Pharma Co., Ltd. | High Dose Injection |
279. Anhui Bengbu Tushan Pharmaceutical Factory | Raw material (Lysinipirinum),Powder Injection |
280. Jiangxi Gannan Pharmaceutical Factory | High Dose Injection |
281. Shenzhen Xinlitai Pharama Co., Ltd. | Powder Injection (Cephalosporin) |
282. Foshan Kangbaoshun Pharma Co., Ltd | Tablet, Granule (Penicillin), Capsule (Penicillin) |
283. Shenyang Sansheng Pharma Co., Ltd. | Recombinant Human Interferona2a |
284. Anhui Dadongfang Pharma Co., Ltd. | Low Dose Injection |
285. Jiangxi Zhuhu Pharma Co., Ltd. | High Dose Injection |
286. Guangdong Bidi Pharma Co., Ltd. | High Dose Injection |
287. Zhuhai Schwarz Co., Ltd. | Tablet |
288. Huangshan Tianmu Pharma Co., Ltd. | Low Dose Injection |
289. Shenzhen Jiuxin Pharma Co., Ltd. | Raw Material (Cephalosporin) |
290. Shunde Shunfeng Pharma Co., Ltd. | Oral Liquid |
291. Huanbei Pharma Group Preparation Co., Ltd | Freeze-dried Powder Injection,Low Dose Injection |
292. Chengdu Tiantaishan Pharma Co., Ltd. | Freeze-dried Powder Injection |
293. Zhejiang Haizheng Pharma Co., Ltd | Powder Injection (Cephalosporin),Freeze-dried Powder Injection |
294. Nanjing Xianhe Pharma Co., Ltd. | Tablet, Capsule |
295. Xuzhou Enhua Phamra Group | High Dose Injection |
296. Zhangjiagang Pharmaceutical Factory | High Dose Injection |
297. Zhejiang Xinguang Pharma Co., Ltd. | Tablet, Capsule, Granule, Oral Liquid |
298. Anhui Tianyang Pharma Co., Ltd. | High Dose Injection |
299. Jiangsu Chen Pharma Co., Ltd. | High Dose Injection |
300. Arabindow Tongling (Datong) Pharma Co., Ltd. | High Dose Injection |
Lehman Lee & Xu
China Lawyers, Notaries, Patent, Copyright and Trademark Agents
http://www.chinalaw.cc/
Beijing Office | Shanghai Office |
188, Beijing International Club
21 Jianguomenwai Dajie, Beijing 100020 China
Tel.: (86)(10) 8532-1919
Fax: (86)(10) 8532-1999
Email: mail@chinalaw.cc | Suite 1902, Central Plaza
227 North Huangpi Road
Shanghai 200003, China
Tel: +86-21 6375-8240-1
Fax: +86-21 6375-8705
Email: shanghai@chinalaw.cc |
To unsubscribe from this newsletter send an email to unsubscribe_lp@chinalaw.cc Please include the email address to which the newsletter is being sent (not a forwarded address) in the body of the email.
The China Lex Pharma Law Newsletter is intended to be used for news purposes only. It should not be taken as comprehensive legal advice, and Lehman, Lee & Xu will not be held responsible for any such reliance on its contents.
